Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Endocarditis II: Clinical Features of Infective Endocarditis

Endocarditis II: Clinical Features of Infective Endocarditis

Endocarditis can present various clinical features depending on the causative organism and the patient's underlying health conditions. Initially, the clinical features of infective endocarditis develop gradually, presenting with nonspecific symptoms that can be easily mistaken for other illnesses.General SymptomsEarly symptoms of infective endocarditis are fever, chills, weakness, malaise, fatigue, and weight loss. These symptoms reflect the systemic nature of the infection and the body's...

Rheumatic Heart Disease I: Introduction

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Distribution of epithelial endoplasmic reticulum stress-related proteins in adult and pediatric Crohn's disease: Association with inflammation and fibrosis.

Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver·2025

Same author

Cardiac amyloidosis: a review of the literature.

Acta cardiologica·2022

Same author

[Inflammatory diseases : anatomo-pathological features].

Revue medicale de Liege·2022

Same author

[Hiccups, not always unremarkable].

Revue medicale de Liege·2022

Same author

[Urethroplasties for male urethral strictures: Success rates and predictive factors].

Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie·2022

Same author

Unusual intra-rectal "laterally spreading tumour" in immunosuppressed patient with ulcerative colitis.

Acta gastro-enterologica Belgica·2021

Same journal

[Nature prescriptions and health promotion : sharing experience from primary care].

Revue medicale de Liege·2026

Same journal

[Eco-health: shared perspectives on primary care practice].

Revue medicale de Liege·2026

Same journal

[The strategic role of primary care in emerging diseases : surveillance, research, and preparedness].

Revue medicale de Liege·2026

Same journal

[Environmental impact of medicines and approaches for more eco responsible use].

Revue medicale de Liege·2026

Same journal

[Climate change and skin].

Revue medicale de Liege·2026

Same journal

[From Silent Spring to neuronal silence : pesticides and neurodegenerative diseases].

Revue medicale de Liege·2026

See all related articles

Search research articles

Related Experiment Video

Updated: Dec 24, 2025

A Metadata Extraction Approach for Clinical Case Reports to Enable Advanced Understanding of Biomedical Concepts

A Metadata Extraction Approach for Clinical Case Reports to Enable Advanced Understanding of Biomedical Concepts

Published on: September 20, 2018

[Erdheim-Chester disease : a case report].

G Delporte¹, I Delcorde², A Rorive³

¹Service d'Anatomie pathologique, CHU Liège, Belgique.

Revue Medicale De Liege

|April 9, 2020

Summary

This summary is machine-generated.

Erdheim-Chester disease, a rare condition, was diagnosed in a woman with inflammatory symptoms. Targeted BRAF and MEK inhibitor therapies successfully improved her symptoms, highlighting a new treatment approach.

Keywords:

BRAF V600E Histiocytosis MAPK Chester disease Erdheim

More Related Videos

Recognition of Epidermal Transglutaminase by IgA and Tissue Transglutaminase 2 Antibodies in a Rare Case of Rhesus Dermatitis

Recognition of Epidermal Transglutaminase by IgA and Tissue Transglutaminase 2 Antibodies in a Rare Case of Rhesus Dermatitis

Published on: December 15, 2011

Minimal Erythema Dose MED Testing

Minimal Erythema Dose MED Testing

Published on: May 28, 2013

Related Experiment Videos

Last Updated: Dec 24, 2025

A Metadata Extraction Approach for Clinical Case Reports to Enable Advanced Understanding of Biomedical Concepts

A Metadata Extraction Approach for Clinical Case Reports to Enable Advanced Understanding of Biomedical Concepts

Published on: September 20, 2018

Recognition of Epidermal Transglutaminase by IgA and Tissue Transglutaminase 2 Antibodies in a Rare Case of Rhesus Dermatitis

Recognition of Epidermal Transglutaminase by IgA and Tissue Transglutaminase 2 Antibodies in a Rare Case of Rhesus Dermatitis

Published on: December 15, 2011

Minimal Erythema Dose MED Testing

Minimal Erythema Dose MED Testing

Published on: May 28, 2013

Area of Science:

Oncology
Hematology
Radiology

Background:

Erdheim-Chester disease (ECD) is a rare non-Langerhans cell histiocytosis characterized by systemic lipid-laden histiocyte infiltration.
Clinical presentation can be diverse, often involving bone, cardiovascular, and central nervous systems, leading to diagnostic challenges.

Observation:

A 47-year-old woman presented with unexplained inflammatory syndrome and asthenia.
Imaging revealed bilateral abnormalities in the femurs and tibias, raising suspicion for Erdheim-Chester disease.
Bone marrow biopsy confirmed the diagnosis of Erdheim-Chester disease.

Findings:

Genetic analysis identified the BRAF V600E mutation in the affected bone marrow.
The presence of the BRAF V600E mutation is a key molecular finding in a subset of Erdheim-Chester disease cases.
This mutation is actionable with targeted therapies.

Implications:

Targeted therapy with BRAF and MEK inhibitors resulted in significant clinical improvement of the patient's symptoms.
This case underscores the importance of molecular profiling, specifically BRAF V600E mutation testing, in Erdheim-Chester disease.
The findings support the use of targeted therapies as an effective treatment strategy for BRAF-mutated Erdheim-Chester disease, potentially improving patient outcomes.